September 26, 2024 09:00 PM EDT

Endpoints 11 winner MediLink Therapeutics: China startup helps power the ADC renaissance

Amber Tong

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease

Exclusive: Drug compounder Empower was built on risky shortcuts, ex-employees and inspections allege

Bristol Myers CEO says America’s biopharma pole position is not guaranteed

Biohaven stock sinks on three-month delay for neuro drug's FDA approval decision

Pathos AI collects $365M to fuel 'bulletproof' oncology trials and in-license more cancer drugs

Updated: Merck KGaA continues US tariff surcharge but at a 'decreased' rate